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Reversible TR in Acute and
Chronic Cardiomyopathy
Medical Versus Surgical Management?
Functional tricuspid regurgitation (TR) has been considered
worthy of repair because of its possible impact on clinical out-
comes (1,2). Nonetheless, no consensus has been reached on the
indications and timing of surgeries. Also, the accurate assessment
of TR severity remains challenging. In the July 2012 issue of
iJACC, Ling et al. (3) provided very helpful information on the
evaluation of TR and right ventricular (RV) dysfunction. In Case
1, they discussed TR in the setting of left ventricular (LV)
dysfunction andmitral regurgitation (MR).We hope to point outFigure 1. TR Signiﬁcantly Improves After 6-Month Medical Manage-
ment of Chronic Cardiomyopathy
Left panels (A to D): before treatment; right panels (E to H): after
treatment. (A and E) Left ventricular (LV) systolic function (shown by
3-dimensional reconstruction) improves after treatment. (B and F) Mitral
regurgitation (MR) (shown by color Doppler, yellow arrows) improves
after treatment. (C and G) tricuspid regurgitation (TR) (shown by color
Doppler, yellow arrows) improves after treatment. See Online Videos 1
and 2. (D and H) TR (shown by continuous wave Doppler) improves after
treatment.chronic and acute cardiomyopathies, with or without MR, which
needs special attention before treatment decisions are made.
Case 1, a 53-year-old woman with diabetes and dyslipidemia,
developed new-onset heart failure. Cardiac catheterization ruled
out ischemia. Echocardiography revealed decreased LV ejection
fraction (LVEF: 11%), severe MR/TR, and dilated tricuspid
valve annulus. After 6-month medical treatment, repeated echo-
cardiography showed improved LVEF (45%) and signiﬁcantly
decreased MR and TR severity (Fig. 1, Online Videos 1 and 2).
Case 2, a 69-year-old woman who developed Takotsubo
cardiomyopathy, echocardiography demonstrated LV outﬂow
tract obstruction and severe MR and TR. After aggressive ﬂuid
resuscitation and beta-blockers, she improved symptomatically.
Repeated echocardiography 4 weeks later revealed that LV
function had normalized, MR had resolved, and the severity of
TR had signiﬁcantly decreased (Fig. 2).
In patients with chronic/acute cardiomyopathies ( MR),
increased LV ﬁlling pressure could increase pulmonary venous
pressure, resulting in secondary RV volume/pressure overload.Figure 2. TR Signiﬁcantly Improves After Acute TC
Left panels (A to D): before Takotsubo cardiomyopathy (TC); right panels
(E to H): after TC. (A and E) LV dysfunction and systolic anterior motion
(red arrow) resolves after TC. (B and F) LV outﬂow tract obstruction and
MR (yellow arrows) improves after TC. (C and G) TR (shown by color
Doppler, yellow arrows) improves after TC. (D and H) TR (shown by
continuous wave Doppler) improves after TC. Abbreviations as in Figure 1.
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921The regurgitant volume of TR might increase dynamically despite
unchanged effective regurgitant oriﬁce area, thus exaggerating TR
severity on echocardiographic assessment. Meanwhile, functional
TR from various chronic and acute cardiomyopathies may sig-
niﬁcantly reverse either by itself or after medical treatment. Thus,
integrated analysis on both cardiac imaging and clinical data of
functional TR is requested before surgical decisions are made.
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For supplementary videos and their legends, please see the online version of
this article.
Bicuspid Aortic Valve Phenotype
and Aortopathy: Nomenclature
and Role of Aortic Hemodynamics
We read with great interest the recently published paper by Kang
et al. (1) regarding the importance of bicuspid aortic valve (BAV)
phenotypic classiﬁcation and its association with valvular dysfunction
and aortopathy. The ﬁndings provide new and valuable data
regarding risk stratiﬁcation of BAV patients according to leaﬂet
morphology. Of particular interest is the potential utility of this in-
formation, combined with knowledge of family history and hemo-
dynamics (2), to provide a better understanding of patient prognosis.
Unfortunately, in the context of the existing literature, the au-
thors chose unconventional nomenclature to stratify BAV phe-
notypes. In the paper, the term BAV-RL designates valves with
free leaﬂets in the lateral position rather than the more common
practice of describing fusion of the right and left coronary leaﬂets
(3–5). Although somewhat arbitrary, this terminology contradicts
the classiﬁcation scheme adapted from one of the key references
(3) and produces yet another naming scheme. The question of
what constitutes a BAV-RL is sure to cause confusion amongst the
community and in future research efforts where nomenclature
swapping propagates and goes unnoticed. This highlights a
growing need for a uniform classiﬁcation scheme, similar to that
proposed by Sievers et al. (4).
Furthermore, the discussion of aortic hemodynamic changes as a
potential link between valve morphology and development of aort-
opathy is somewhat incomplete. Although we strongly agree that
BAVs alter aortic hemodynamics, as has recently been shown by usand others, the assertion that left-handed helical ﬂow exists in the
BAV phenotype with free leaﬂets in the lateral position is unproven,
with a single-center report in the literature.
Our experience is that the orientation of the ﬂow helix is pre-
dominantly right-handed. We and others have shown that the
incomplete opening of the BAV results in an abnormal ﬂow jet
dependent on the position of a conjoint leaﬂet. In the case of lateral
leaﬂet fusion, the conjoint leaﬂet can cause a ﬂow jet to reﬂect off of
the inner arch curvature and impinge on the greater arch at a more
downstream position, thereby causing helical ﬂow with right-handed
orientation (5). In addition, the authors did not address recent de-
velopments that have shown that magnetic resonance imaging can be
used to directly quantify the impact of aortic valve disease on the
aortic wall by means of metrics such as segmental wall shear stress (5).
In this context, aortic wall shear stress is altered regardless of the
orientation of helix ﬂow and may be a more fundamental parameter
to investigate for abnormal aortic remodeling.
In essence, we believe that the data of Kang et al. (1) are an
important step toward understanding the role genetics and
mechanotransduction may play in BAV-mediated aortopathy. We
agree that advanced imaging techniques offer promising diagnostic
imaging tools. However, a consistent description of the subtle var-
iations in valve morphology, as well as newly developed in vivo
metrics of hemodynamic changes associated with aortic valve dis-
ease, should not be overlooked: without a uniform classiﬁcation
scheme, we run the risk of confounding future efforts.
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REPLY : Bicuspid Aortic Valve Phenotype and Aortopathy:
Nomenclature and Role of Aortic Hemodynamics
We thank for Drs. Barker, Robinson, and Markl for their interest in
our paper (1). They were concerned about the potential confusion
caused by our using the term BAV-RL to designate the spatial
orientation of a bicuspid aortic valve (BAV) in cases where the right
or left coronary cusp is fused with the noncoronary cusp. They
